Ying Liu

机构：Hebei Medical University, Second Hospital of Hebei Medical University · ORCID：0000-0002-2304-5557

发表论文 32 篇 · 总被引 892 次 · h-index 10

代表论文

• Sintilimab Plus Chemotherapy for Unresectable Gastric or Gastroesophageal Junction Cancer (2023 · JAMA · 被引 404)
• Efficacy and safety of neoadjuvant sintilimab, oxaliplatin and capecitabine in patients with locally advanced, resectable gastric or gastroesophageal junction adenocarcinoma: early results of a phase 2 study (2022 · Journal for ImmunoTherapy of Cancer · 被引 116)
• Short-term surgical outcomes of laparoscopy-assisted versus open D2 distal gastrectomy for locally advanced gastric cancer in North China: a multicenter randomized controlled trial (2018 · Surgical Endoscopy · 被引 101)
• The neuroprotection of hyperbaric oxygen therapy against traumatic brain injury via NF-κB/MAPKs-CXCL1 signaling pathways (2021 · Experimental Brain Research · 被引 57)
• High-Expression HBO1 Predicts Poor Prognosis in Gastric Cancer (2019 · American Journal of Clinical Pathology · 被引 42)
• Pathogenic Functions of Tumor Necrosis Factor Receptor-Associated Factor 6 Signaling Following Traumatic Brain Injury (2021 · Frontiers in Molecular Neuroscience · 被引 34)